Ofatumumab monotherapy as a consolidation strategy in patients with previously untreated chronic lymphocytic leukaemia: a phase 2 trial-Reference-Cited by-同舟云学术

Ofatumumab monotherapy as a consolidation strategy in patients with previously untreated chronic lymphocytic leukaemia: a phase 2 trial

Published:2016-09 Issue:9 Volume:3 Page:e407-e414
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Strati Paolo,Lanasa Mark,Call Timothy G,Leis Jose F,Brander Danielle M,LaPlant Betsy R,Pettinger Adam M,Ding Wei,Parikh Sameer A,Hanson Curtis A,Chanan-Khan Asher A,Bowen Deborah A,Conte Michael,Kay Neil E,Shanafelt Tait D

Publisher

Elsevier BV

Subject

Hematology

Reference41 articles.

1. Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial;Hallek;Lancet,2010

2. Eichhorst B, Fink AM, Busch R, et al. Chemoimmunotherapy with fludarabine (F), cyclophosphamide (C), and rituximab (R) (FCR) versus bendamustine and rituximab (BR) in previously untreated and physically fit patients (pts) with advanced chronic lymphocytic leukemia (CLL): results of a planned interim analysis of the CLL10 trial, an international, randomized study of the German CLL Study Group (GCLLSG). 55th American Society of Hematology Annual Meeting and Exposition; New Orleans, LA, USA; Dec 7–10, 2013. Abstract 526.

3. Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia;Burger;N Engl J Med,2015

4. Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia;Keating;J Clin Oncol,2005

5. Pentostatin, cyclophosphamide, and rituximab regimen in older patients with chronic lymphocytic leukemia;Shanafelt;Cancer,2007

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maintenance therapy for chronic lymphocytic leukaemia;Cochrane Database of Systematic Reviews;2024-01-04

2. Targeted therapy;Medicines for Cancer;2023

3. Fungal infections following treatment with monoclonal antibodies and other immunomodulatory therapies;Revista Iberoamericana de Micología;2020-01

4. Biological Therapy of Hematologic Malignancies: Toward a Chemotherapy- free Era;Current Medicinal Chemistry;2019-05-13

5. Canadian Evidence-Based Guideline for the First-Line Treatment of Chronic Lymphocytic Leukemia;Current Oncology;2018-10-01